
Growth Rates of Genetically Defined Renal Tumors: Implications for Active Surveillance and Intervention
Author(s) -
Mark W. Ball,
Julie Y. An,
Patrick T. Gomella,
Rabindra Gautam,
Christopher J. Ricketts,
Cathy D. Vocke,
Laura S. Schmidt,
María J. Merino,
Ramaprasad Srinivasan,
Ashkan A. Malayeri,
Adam R. Metwalli,
W. Marston Linehan
Publication year - 2020
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.19.02263
Subject(s) - medicine , interquartile range , germline , germline mutation , kidney , bap1 , cancer , oncology , cancer research , mutation , biology , genetics , gene
Published series of growth rates of renal tumors on active surveillance largely consist of tumors without pathologic or genetic data. Growth kinetics of genetically defined renal tumors are not well known. Here, we evaluate the growth of genetically defined renal tumors and their association with patient clinical and genetic characteristics.